GUANGZHOU-INFORMATION
18.11.2023 13:07:35 CET | Business Wire | Press release
China’s Guangzhou launched a special conversation on November 16 in Italy’s Rome, at which more than a dozen guests from both countries told their stories about cultural and economic cooperation, showcased the fruitful achievements between two sides.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231118396482/en/
China’s Guangzhou launches conversations between China and Italy to showcase the cooperation achievements. (Graphic: Business Wire)
Guangzhou, a metropolis in southern China, has been a trade gateway of China to the world for more than two thousand years.
According to Sun Yong, publicity director of Nansha District of Guangzhou, “At that time, Guangzhou received merchant ships from all over the world including Italy, when marked the prosperity of Maritime Silk Road.”
“Today, the world's largest luxury ro-ro passenger ship MOBY, operating in the Italian Mediterranean, was actually built by Guangzhou Shipyard International based in Nansha,” Sun continued, “we are still connected.”
Michele De Gasperis, President of the Italian One Belt One Road Institute, said that Guangzhou is not only a beautiful city, but also a city full of business opportunities.
“Recently I visited the Canton Fair held in Guangzhou and was deeply impressed. I firmly believe that Guangzhou will become an important trade and tourism destination in Italy,” said Gasperis.
During the event, the Italian pianist Giuseppe Ganzerli, performed with PEARL River piano. “I started to import Pearl River piano from Guangzhou for more than ten years. Pearl River is a beautiful river across Guangzhou city. I always tell my Italian clients that this piano is so beautiful just like the Pearl River itself,” said Gennaro Schlitzer, board member of Queen’s SRL.
Several chefs from Guangzhou Restaurants Group demonstrated Guangzhou cuisine at the event.
“Canton is famous for its unique cuisine, which has reached every corner of the world. But our relationship goes far beyond cooking,” Angelo Tabaro, former minister for culture of the Veneto Region said.
“Italy and China are the two nations with the longest-lived and richest cultural heritages.” He added, “From painting to music, literature to architecture, both countries have influenced the world in unique ways. Italian and Chinese companies collaborate in sectors ranging from automobiles to fashion, from technology to renewable energy.”
Edouard Suzeau, a young designer from Guangzhou Automobile Group (GAC) Design Studio Milan, said that “Milan was chosen as the location for our studio because the city’s ubiquitous car culture is a perfect fit with GAC’s mission and passion for automotive design.”
A modern sculpture called Embrace the World made by Guangzhou artist Zeng Zhenwei, was given to Laura Gallon, President of the Italian Arte Laguna Prize. “I believe that the art and culture exchange between our two nations can be carried forward,” Gallon said.
Statistic shows that in 2022, the bilateral trade volume between China and Italy reached US$77.9 billion, hit a record high.
“More exchanges in all sectors are expected,” Li Ran from China southern airlines said, “For example, we currently operate four round-trip flights per week between Guangzhou and Rome, and will increase to six per week in December this year.”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231118396482/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
